MRK
Merck & Co., Inc.
Stock
$148.69−0.09 (−0.06%)Close Sep 28, 2026
MRK's net income for 2025 was $18.25 billion, up 6.6% from the year before.
From SEC filings, Latest filing: 10-Q, Aug 7, 2026
| Net income (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $3.173B | −80.7% | 20.9% | 15.2% |
| Net income (TTM) | $3.173B |
|---|---|
| YoY | −80.7% |
| 5-year CAGR | 20.9% |
| 10-year CAGR | 15.2% |
Net income
| Period | Net income | YoY |
|---|---|---|
| 2025 | $18.3B | +6.6% |
| 2024 | $17.1B | +4,589.6% |
| 2023 | $0.4B | −97.5% |
| 2022 | $14.5B | +11.3% |
| 2021 | $13.0B | +84.6% |
| 2020 | $7.1B | −28.2% |
| 2019 | $9.8B | +58.2% |
| 2018 | $6.2B | +159.8% |
| 2017 | $2.4B | −38.9% |
| 2016 | $3.9B | −11.8% |
| 2015 | $4.4B | −62.7% |
| 2014 | $11.9B | +170.7% |
| 2013 | $4.4B | −28.6% |
| 2012 | $6.2B | −1.7% |
| 2011 | $6.3B | +628.5% |
| 2010 | $0.9B | −93.3% |
| 2009 | $12.9B | +65.2% |
| 2008 | $7.8B | +138.4% |
| 2007 | $3.3B | — |